UK – The global food and beverage ingredients supplier, Tate & Lyle has announced a collaborative research project with APC Microbiome Ireland, a Science Foundation Institute (SFI) Research Centre on dietary fibre research.

Funded by the two companies, the research project seeks to identify potential health benefits of dietary fibres for specific age groups among consumers.

Additionally, it will explore the benefit of these fibres for specific improved health outcomes, particularly relating to cardio-metabolic health. 

The partnership will leverage on APC Microbiome Ireland’s global leadership in microbiome science, given that the institution is ranked number one globally for research in antimicrobial and therapeutic microbes.

“By growing and expanding international links through partnerships and collaborations with such world-leading organisations, the SFI Research Centres are creating opportunities for innovation and global knowledge transfer.

It is a tribute to our researchers in Ireland that Tate & Lyle is committing to this research partnership and I look forward to seeing the fruits of this collaboration in the future,” said Prof Mark Ferguson, Director General, Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland.

Formed in 2003, SFI Research Centre APC Microbiome Ireland is a leading research institute funded by Science Foundation Ireland, leading in gut microbiota research.

APC Microbiome Ireland has expanded the research and development capabilities of Ireland in an area of immediate relevance to the food and pharmaceutical sectors of industry.

According to Tate & Lyle, certain dietary fibres have been found to have prebiotic effects, feeding ‘good’ bacteria in the gut and promoting a healthy composition of ‘gut microbiome’.

The collaboration is critical for Tate & Lyle as it strives to meet the demands of customers who are increasingly becoming aware of the health benefits of dietary fibre.

“Dietary fibre provides a wide range of health benefits, including digestive health, keeping blood glucose levels healthy, weight management, cholesterol reduction and possibly even bone health,” said Andrew Taylor, President, Innovation and Commercial Development, Tate & Lyle.

At Tate & Lyle, we are excited by the potential our fibres have to address significant societal health challenges, and by working with APC Microbiome Ireland we’re committed to building further the evidence base around the positive role fibre can play in improving public health.”